- Home
- EVMN vs JQC Comparison
EVMN vs JQC Comparison
Compare EVMN & JQC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVMN | JQC |
|---|---|---|
| Founded | 2020 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 628.9M | 753.9M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | EVMN | JQC |
|---|---|---|
| Price | $17.01 | $5.06 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $39.33 | N/A |
| AVG Volume (30 Days) | 189.2K | ★ 714.6K |
| Earning Date | 12-11-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.13% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,000,000.00 | N/A |
| Revenue This Year | $89.43 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 160.00 | N/A |
| 52 Week Low | $13.89 | $4.82 |
| 52 Week High | $24.03 | $5.65 |
Technical Indicators
Market Signals| Indicator | EVMN | JQC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 51.74 |
| Support Level | N/A | $4.96 |
| Resistance Level | N/A | $5.02 |
| Average True Range (ATR) | 0.00 | 0.04 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 79.17 |
Price Performance
Historical ComparisonAbout EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
About JQC Nuveen Credit Strategies Income Fund Shares of Beneficial Interest
Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.